Sphygmomanometer for fibromyalgia detection in rheum OPD 🔥⬆️local pain during BP testing strongly indicates presence of FMS ✅useful, easily applicable and practical screening tool Abst#1225 #ACR22 @RheumNow

#FMF 2350 pts = 40% with arthritis - Colchicine resistance in 20% - M694V mutation carrier rate high (mutant MEFV gene) - FMF pts with arthritis have a more severe disease course - incidence of spondyloarthropathy was increased in FMF #ACR22 @RheumNow abst#1830 https://t.co/uiLhjK0UjY

Rohmer @TerrierBen et al. 196 cases of PAN from France. 28% assoc another condition - MDS and cancer mainly. Relapse in 39% - assoc age>65, GI, skin necrosis. Death assoc age>65, AKI, secondary PAN, necrotic purpura. @RheumNow #ACR22 Abstr#2232 https://t.co/fyJY9O3Gm7

• Clinical Features and Long-term Outcomes of Patients with Systemic Polyarteriti…

Tonight! Join our RA Topic Panel with panelists: Drs. Richard Conway, Aurelie Najm, David Liew, Janet Pope, Julian Segan @RichardPAConway @AurelieRheumo @drdavidliew @Janetbirdope @JulianSegan #ACR22 https://t.co/j13W4GM56w https://t.co/fgDwPVdskC

• https://bit.ly/3Ah5caJ

RheumNow’s expanded coverage of the #ACR22 Annual meeting is sponsored in part by Novartis. All content chosen by RheumNow & its Faculty.

Curtis et al. Primary non-adherence to csDMARDs and b/tsDMARDs in RA/PsA/SpA. Medicare and commerically-insured patients. 20-44%! of new prescriptions not filled by 6 months. Higher for csDMARDs than b/tsDMARDs @RheumNow #ACR22 Abstr#2199 https://t.co/Pwg6GKu7Gg https://t.co/wPF0pu1UDa

• Primary Non-adherence to Biologics and Immunomodulatory Therapies for Rheumatoi…

Abstr #2192 risk of serious infxn in newborns of mothers on TNFi by placental transfer - % serious infection in TNFi in high vs low placental transfer (2.1% vs 1.6%) - HR (high vs low) 0.98 (95% CI 0.36-2.61) - No significant difference in risk of serious infxn @RheumNow #ACR22 https://t.co/7Lfpf7PERu

Which patients with IIM are high risk for #cancer? Abstract #0002 #ACR22 @RheumNow #ACRBest 📍Dermatomyositis 📍Anti-TIF-gamma, anti-NXP2 📍Age > 40y at dz onset 📍Dysphagia 📍Cutaneous necrosis 📍Persistent high dz despite immunosuppressive tx

Which is better for CV risk in RA: triple therapy DMARDs or TNFi? TARGET study n=159 using PET/CT surrogate (endpoint responsiveness👀) - either led to benefit - both equally good - benefit *not* linked to change in DAS28 A direct CV effect of RA Rx? ABST2215 #ACR22 @RheumNow https://t.co/4FPvSbfGsD

Vaccination +/- prior Covid-19, and with either mRNA or vectored DNA vaccines were not associated with AIRD flares. Negative association 21-days after 1st Covid-19 vaccination and no association after 2nd or 3rd doses. Nakafero G Abs#2194 https://t.co/vA8cMNQGkr #ACR22 @RheumNow https://t.co/SZnXejnmYt

• Is Vaccination Against Covid-19 Associated with Autoimmune Rheumatic Disease Fl…

Singh @NamrataRheum et al. Frailty in patients treated bDMARD/tsDMARD assoc serious infections aHR 1.34, any infection aHR 1.18, hospitalisation aHR 1.34 (all relative non-frail). @RheumNow #ACR22 Abstr#2218 https://t.co/ONsTBq8ehB https://t.co/iTVANh5flk

• Frailty Is Associated with Serious Infections in Biologic and Targeted-syntheti…

Thieves Market #ACR22 Ulcerative palatal lesions, non-spec bx +ANA 1:320 w other neg Abs Empiric steroids for presumed vasculitis New cavitary lung lesion. Pathology showed vasculitis Dacrocystitis w lobulated paranasal mass Dx: Extra nodal NK/T-cell lymphoma Fatal case @RheumNow https://t.co/TlDy9GfW7N

Flatman et al. Risk of infections in children with third trimester TNFi use, high vs low (CTZ, ETN) placental transfer. No difference but wide CIs, aHR 0.98 (0.36, 2.61) @RheumNow #ACR22 Abstr#2192 https://t.co/350UxX9bkL https://t.co/29uOtek8w7

• Serious Infections in Offspring Exposed During Late Pregnancy to Tumour Necrosi…